Andrew R. Lloyd

27.0k total citations · 3 hit papers
457 papers, 19.5k citations indexed

About

Andrew R. Lloyd is a scholar working on Hepatology, Epidemiology and Psychiatry and Mental health. According to data from OpenAlex, Andrew R. Lloyd has authored 457 papers receiving a total of 19.5k indexed citations (citations by other indexed papers that have themselves been cited), including 169 papers in Hepatology, 160 papers in Epidemiology and 101 papers in Psychiatry and Mental health. Recurrent topics in Andrew R. Lloyd's work include Hepatitis C virus research (169 papers), Hepatitis B Virus Studies (106 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (84 papers). Andrew R. Lloyd is often cited by papers focused on Hepatitis C virus research (169 papers), Hepatitis B Virus Studies (106 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (84 papers). Andrew R. Lloyd collaborates with scholars based in Australia, United States and United Kingdom. Andrew R. Lloyd's co-authors include Denis Wakefield, Ian B. Hickie, Joost J. Oppenheim, David J. Kelvin, Gregory J. Dore, Uté Vollmer‐Conna, Dennis D. Taub, Kevin Conlon, Barbara Cameron and David Adams and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Andrew R. Lloyd

433 papers receiving 18.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells.

1993 675 citations Andrew R. Lloyd et al. profile →
Preferential Migration of Activated CD4 ⁺ and CD8 ⁺ T Cells in Response to MIP-1α and MIP-1β

1993 666 citations Andrew R. Lloyd et al. profile →
Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study

2006 572 citations Ian B. Hickie, Uté Vollmer‐Conna et al. profile →

Peers

Countries citing papers authored by Andrew R. Lloyd

Since Specialization

Citations

This map shows the geographic impact of Andrew R. Lloyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew R. Lloyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew R. Lloyd more than expected).

Fields of papers citing papers by Andrew R. Lloyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew R. Lloyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew R. Lloyd. The network helps show where Andrew R. Lloyd may publish in the future.

Co-authorship network of co-authors of Andrew R. Lloyd

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew R. Lloyd. A scholar is included among the top collaborators of Andrew R. Lloyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew R. Lloyd. Andrew R. Lloyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	People and Families Affected by Glycogen Storage Disease Type Ia: An Analysis of Narrative Accounts Written by Individuals Living with GSDIa and Their Caregivers 2025 ·Journal of health economics and outcomes research ·Eliza Kruger, (unknown), (unknown), (unknown), Andrew R. Lloyd	1
2	Single-Cell RNA Sequencing of Murine Limbal Epithelia Reveals Gas1 as a Novel Stem/Progenitor Cell Marker for the Corneal Epithelium 2025 ·Cornea ·Alexander Richardson, Susan Corley, Naomi C. Delic, (unknown), Andrew R. Lloyd, Nick Di Girolamo	0
3	Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit 2024 ·International Journal of Drug Policy ·Shelley Walker, Lok Bahadur Shrestha, Andrew R. Lloyd, (unknown), Yumi Sheehan, (unknown), (unknown), Joaquín Cabezas, Matthew J. Akiyama, Nadine Kronfli	7
4	Hepatitis C treatment outcome among people in prison: The SToP‐C study 2024 ·Liver International ·Hannah Ryan, Gregory J. Dore, Jason Grebely, Marianne Byrne, Evan B. Cunningham, Marianne Martinello, Andrew R. Lloyd, Behzad Hajarizadeh	2
5	Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide 2024 ·Journal of Hepatology ·Marı́a Buti, Heiner Wedemeyer, Soo Aleman, Vladimir Chulanov, Viacheslav Morozov, Olga Sagalova, (unknown), Robert G. Gish, Andrew R. Lloyd, (unknown), Vithika Suri, (unknown), Anu Osinusi, John F. Flaherty, Pietro Lampertico	7
6	Using nominal group technique with people who are incarcerated in Canadian federal prisons to identify barriers and solutions to improving Prison Needle Exchange Program uptake 2024 ·International Journal of Drug Policy ·Lise Lafferty, Frederick L. Altice, Frédéric Leone, Mark Stoové, Andrew R. Lloyd, Behzad Hajarizadeh, Nadine Kronfli	10
7	The Patient's Experience of Working with Multiple Allied Health Professional Students – A Qualitative Interview Study 2024 ·Journal of Patient Experience ·(unknown), (unknown), (unknown), Andrew R. Lloyd, (unknown), (unknown)	0
8	Prevalence and Characteristics Associated With Post–COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults 2023 ·JAMA Network Open ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Gunnar Einvik, Truls Michael Leegaard, Trygve Tjade, Annika E. Michelsen, Tom Eirik Mollnes, Fridtjof Lund‐Johansen, Trygve Holmøy, Henrik Zetterberg, Kaj Blennow, Carolina X. Sandler, Erin Cvejic, Andrew R. Lloyd, Vegard Bruun Wyller	59
9	The path to hepatitis C elimination: who are we leaving behind and why? 2023 ·Journal of the International AIDS Society ·Jürgen K. Rockstroh, Tracy Swan, Judy Chang, (unknown), Andrew R. Lloyd	10
10	Genomic Surveillance of Recent Dengue Outbreaks in Colombo, Sri Lanka 2023 ·Viruses ·(unknown), Braulio M. Valencia, Chathurani Sigera, Thiruni Adikari, Praveen Weeratunga, Deepika Fernando, Senaka Rajapakse, Andrew R. Lloyd, Rowena A. Bull, Chaturaka Rodrigo	8
11	A unique cytotoxic CD4 ⁺ T cell‐signature defines critical COVID‐19 2023 ·Clinical & Translational Immunology ·Sarah Baird, Caroline L. Ashley, Felix Marsh‐Wakefield, (unknown), Thomas M. Ashhurst, Angela L. Ferguson, (unknown), Claudio Counoupas, Jeffrey J. Post, Pamela Konecny, Adam Bartlett, Marianne Martinello, Rowena A. Bull, Andrew R. Lloyd, (unknown), (unknown), Umaimainthan Palendira, Warwick J. Britton, Megan Steain, James A. Triccas	2
12	Trends in intravenous immunoglobulin use in New South Wales, Australia 2023 ·Internal Medicine Journal ·James Wood, Anita Heywood, (unknown), Andrew R. Lloyd, John B. Ziegler	2
13	Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases 2022 ·Translational Psychiatry ·(unknown), Adam K. Walker, Maryanne O׳Donnell, Cherrie Galletly, Andrew R. Lloyd, Dennis Liu, Cynthia Shannon Weickert, Thomas W. Weickert	22
14	CD73+ CD127high Long-Term Memory CD4 T Cells Are Highly Proliferative in Response to Recall Antigens and Are Early Targets in HIV-1 Infection 2021 ·International Journal of Molecular Sciences ·Nabila Seddiki, John Zaunders, Chansavath Phetsouphanh, Vedran Brezar, Yin Xu, Helen M. McGuire, Michelle Bailey, (unknown), (unknown), C. Mee Ling Munier, Laura Cook, Stephen J. Kent, Andrew R. Lloyd, Barbara Cameron, Barbara Fazekas de St Groth, Kersten K. Koelsch, Mark Danta, Hakim Hocini, Yves Lévy, Anthony D. Kelleher	4
15	B-cell receptor reconstruction from single-cell RNA-seq with VDJPuzzle 2018 ·Bioinformatics ·Simone Rizzetto, David Koppstein, Jerome Samir, Mandeep Singh, Joanne H. Reed, Curtis Cai, Andrew R. Lloyd, Auda A. Eltahla, Christopher C. Goodnow, Fabio Luciani	66
16	Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework 2018 ·Liver International ·(unknown), Margaret Hellard, Carla Treloar, Julie Bruneau, Natasha K. Martin, Anne Øvrehus, Olav Dalgård, Andrew R. Lloyd, John Dillon, Matthew Hickman, Jude Byrne, Alain H. Litwin, Mojca Matičič, Philip Bruggmann, Håvard Midgard, Brianna L. Norton, Stacey Trooskin, Jeffrey V. Lazarus, Jason Grebely, (unknown)	83
17	Autonomic nervous system function, activity patterns, and sleep after physical or cognitive challenge in people with chronic fatigue syndrome 2017 ·Journal of Psychosomatic Research ·Erin Cvejic, Carolina X. Sandler, Andrew Keech, B. Benjamin, Andrew R. Lloyd, Uté Vollmer‐Conna	15
18	Characterisation of the cytokine milieu associated with the up‐regulation of IL‐6 and suppressor of cytokine 3 in chronic hepatitis C treatment non‐responders 2014 ·Liver International ·(unknown), Clovis S. Palmer, David Simar, Barbara Cameron, Nam Nguyen, (unknown), Andrew R. Lloyd, Amany Zekry	5
19	A Twin Study of the Etiology of Prolonged Fatigue and Immune Activation 2001 ·Twin Research ·Ian B. Hickie, Amolak S. Bansal, Katherine M. Kirk, Andrew R. Lloyd, Nicholas G. Martin	5
20	A Twin Study of the Etiology of Prolonged Fatigue and Immune Activation 2001 ·Twin Research ·Ian B. Hickie, Amolak S. Bansal, Katherine M. Kirk, Andrew R. Lloyd, Nicholas G. Martin	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact